July 02, 2026

Immediate Repair Successful After Urethral Injury

Case report described successful immediate reconstruction of a membranous urethral injury recognized during rectal cancer surgery.

Conexiant

June 25, 2026

Prehabilitation Program May Benefit Patients Undergoing CRC Surgery

Structured implementation increased participation and improved preoperative fitness, while postoperative complication and mortality rates remained similar across groups.

Conexiant

June 18, 2026

Top 10 FDA Recalls Physicians Should Know

A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.

Conexiant

June 12, 2026

Language Barriers Linked to Cancer Treatment Delays

Texas registry data point to neighborhood-level vulnerability as a possible target for improving timely colorectal cancer care.

Conexiant

June 08, 2026

Surgeons Describe Rescue Barriers

Interviews with surgeons linked rescue failures to hierarchy, self-reliance, communication barriers, and system pressures.

Conexiant

May 12, 2026

7 Days Noninferior in Bacteremia

BALANCE compared 7 vs 14 days of treatment among hospitalized patients with bloodstream infections.

Conexiant

May 08, 2026

Funnel Mesh Reduced Parastomal Hernias

Randomized trial found lower hernia rates at 3 years with no increase in mesh-related complications

Conexiant

May 06, 2026

Postoperative Step Counts Tied to Surgical Recovery

Wearable-measured mobility—but not heart rate variability or wellness scores—was associated with length of stay, complications, and readmissions

Conexiant

May 05, 2026

1-L Prep Boosts Quality, Not Adequacy

Randomized trial in hospitalized patients found improved high-quality bowel cleansing with 1-L regimen, though primary endpoint differences were not statistically significant

Conexiant

May 01, 2026

Neoadjuvant Chemo Did Not Improve Disease-Free Survival

Phase 3 NeoCol trial adds to mixed evidence as field shifts toward biomarker-guided approaches

Conexiant